Iofina
Market Cap
UK£24.0m
Last Updated
2021/02/26 18:32 UTC
Data Sources
Company Financials +
Executive Summary
Iofina plc engages in the exploration and production of iodine, iodine specialty chemical derivatives, produced water, and natural gas in the United States and the United Kingdom. More Details
Rewards
Risk Analysis
Snowflake Analysis
Very undervalued with high growth potential.
Share Price & News
How has Iofina's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: IOF is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: IOF's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.
Market Performance
7 Day Return
-0.4%
IOF
-1.7%
GB Chemicals
0.2%
GB Market
1 Year Return
-40.5%
IOF
27.4%
GB Chemicals
-0.2%
GB Market
Return vs Industry: IOF underperformed the UK Chemicals industry which returned 23.1% over the past year.
Return vs Market: IOF underperformed the UK Market which returned -3.7% over the past year.
Shareholder returns
| IOF | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.4% | -1.7% | 0.2% |
| 30 Day | 2.0% | -0.5% | 0.5% |
| 90 Day | -7.4% | 14.3% | 6.3% |
| 1 Year | -40.5%-40.5% | 29.5%27.4% | 5.8%-0.2% |
| 3 Year | -33.9%-33.9% | 9.1%-1.5% | 10.3%-2.9% |
| 5 Year | 96.5%96.5% | 45.5%22.9% | 41.3%14.0% |
Long-Term Price Volatility Vs. Market
How volatile is Iofina's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
What Is Iofina plc's (LON:IOF) Share Price Doing?1 month ago | Simply Wall St
Is Weakness In Iofina plc (LON:IOF) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?2 months ago | Simply Wall St
Will the Promising Trends At Iofina (LON:IOF) Continue?Valuation
Is Iofina undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: IOF (£0.13) is trading below our estimate of fair value (£0.25)
Significantly Below Fair Value: IOF is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: IOF is good value based on its PE Ratio (15.6x) compared to the GB Chemicals industry average (39.4x).
PE vs Market: IOF is good value based on its PE Ratio (15.6x) compared to the UK market (23.9x).
Price to Earnings Growth Ratio
PEG Ratio: IOF is good value based on its PEG Ratio (0.2x)
Price to Book Ratio
PB vs Industry: IOF is good value based on its PB Ratio (1.6x) compared to the GB Chemicals industry average (3.1x).
Next Steps
Future Growth
How is Iofina forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
79.1%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IOF's forecast earnings growth (79.1% per year) is above the savings rate (1%).
Earnings vs Market: IOF's earnings (79.1% per year) are forecast to grow faster than the UK market (23.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: IOF's revenue (10.4% per year) is forecast to grow faster than the UK market (7.3% per year).
High Growth Revenue: IOF's revenue (10.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IOF's Return on Equity is forecast to be high in 3 years time (20.1%)
Next Steps
Past Performance
How has Iofina performed over the past 5 years?
29.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IOF has high quality earnings.
Growing Profit Margin: IOF became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: IOF has become profitable over the past 5 years, growing earnings by 29.3% per year.
Accelerating Growth: IOF has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: IOF has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-33%).
Return on Equity
High ROE: IOF's Return on Equity (10.5%) is considered low.
Next Steps
Financial Health
How is Iofina's financial position?
Financial Position Analysis
Short Term Liabilities: IOF's short term assets ($20.4M) do not cover its short term liabilities ($21.6M).
Long Term Liabilities: IOF's short term assets ($20.4M) exceed its long term liabilities ($1.2M).
Debt to Equity History and Analysis
Debt Level: IOF's debt to equity ratio (80%) is considered high.
Reducing Debt: IOF's debt to equity ratio has reduced from 83.4% to 80% over the past 5 years.
Debt Coverage: IOF's debt is not well covered by operating cash flow (18.4%).
Interest Coverage: IOF's interest payments on its debt are not well covered by EBIT (2.4x coverage).
Balance Sheet
Next Steps
Dividend
What is Iofina current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate IOF's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate IOF's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if IOF's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IOF's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IOF's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
6.4yrs
Average management tenure
CEO
Tom Becker (50 yo)
6.42yrs
Tenure
US$275,600
Compensation
Dr. Thomas Matthew Becker, also known as Tom, has been the Chief Executive Officer and President of Iofina plc since September 5, 2014. Dr. Becker served as the President of Iofina Chemical Inc., at Iofina...
CEO Compensation Analysis
Compensation vs Market: Tom's total compensation ($USD275.60K) is about average for companies of similar size in the UK market ($USD341.60K).
Compensation vs Earnings: Tom's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Director | 6.42yrs | US$275.60k | 0.065% $ 15.6k | |
| CFO & Executive Director | 4.25yrs | US$190.00k | 0.049% $ 11.7k | |
| Chief Operating Officer of Iofina Resources Inc | 5yrs | no data | no data | |
| Chief Operating Officer of Iofina Chemical Inc | 6.42yrs | no data | no data | |
| Company Secretary | 7.67yrs | no data | no data |
6.4yrs
Average Tenure
57.5yo
Average Age
Experienced Management: IOF's management team is seasoned and experienced (6.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Director | 6.42yrs | US$275.60k | 0.065% $ 15.6k | |
| CFO & Executive Director | 4.25yrs | US$190.00k | 0.049% $ 11.7k | |
| Independent Non-Executive Director | 2.25yrs | US$30.00k | 0.012% $ 3.0k | |
| Non-Executive Chairman | 6.83yrs | US$109.62k | 2.61% $ 626.6k | |
| Independent Non-Executive Director | 0.83yr | no data | no data | |
| Independent Non-Executive Director | 6.92yrs | US$30.00k | 0.024% $ 5.9k |
5.5yrs
Average Tenure
64.5yo
Average Age
Experienced Board: IOF's board of directors are considered experienced (5.5 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: IOF insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Iofina plc's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Iofina plc
- Ticker: IOF
- Exchange: AIM
- Founded: 2005
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: UK£23.982m
- Shares outstanding: 191.86m
- Website: https://www.iofina.com
Number of Employees
Location
- Iofina plc
- 48 Chancery Lane
- London
- Greater London
- WC2A 1JF
- United Kingdom
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| IOF | AIM (London Stock Exchange AIM Market) | Yes | Ordinary Shares | GB | GBP | May 2008 |
| IF7 | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | May 2008 |
| IOFN.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | May 2008 |
Biography
Iofina plc engages in the exploration and production of iodine, iodine specialty chemical derivatives, produced water, and natural gas in the United States and the United Kingdom. It offers halogen chemica...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/02/26 18:32 |
| End of Day Share Price | 2021/02/26 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.